Serial Number:
97009404
Mark:
KNOA PHARMACEUTICALS
Status:
Second Extension-Granted
Status Date:
06-25-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
A house mark for a full line of pharmaceuticals; pharmaceuticals for use in the treatment of central nervous system disorders, pain, opioid overdose, opioid reversal, opioid use disorders, interstitial cystitis/bladder pain syndrome (IC/BPS), Overactive Bladder (OAB), Alcohol Use Disorder, Substance Use Disorder, sleep disorders including Insomnia Associated with Alcohol Cessation (IAAC), anaphylaxis; pharmaceuticals for use in the treatment of oncology conditions, specifically glioblastoma multiforme (GBM), non Hodgkin lymphoma, solid tumors, melanoma, chronic myelogenous leukemia, hemato-oncology, refractory/relapsed malignancies, alone or in combination with other agents; analgesics; pharmaceuticals, namely, opioid antagonists; syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; syringes filled with opioid antagonists; injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectors filled with opioid antagonists; injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; injectable pharmaceuticals, namely, opioid antagonists Pharmaceutical research and development
Mark Description:
N/A
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
05-02-2023
Owner:
Mark Drawing Status:
4
Abandon Date:
N/A
Business Name:
51 WEST 52ND STREET
Correspondent Name:
